Purpose Hepatocellular carcinoma (HCC), a common cause for cancer-related death, is
increasing worldwide. Over the past decade, survival and quality of life of HCC patients have …

Hepatocellular carcinoma (HCC) is the fifth most common neoplasm, the major cause of
death in patients with liver cirrhosis, and the third most common cause of cancer-related …

AIM: To review all of epidemiological and etiological aspects of hepatocellular carcinoma
(HCC) and examined the prevention of this disease in Asia. METHODS: We conducted a …

The interdisciplinary guidelines at the S3 level on the diagnosis of and therapy for
hepatocellular carcinoma (HCC) constitute an evidence-and consensus-based instrument …

Background: Hepatocellular carcinoma (HCC) is the most common type of liver cancer and
causes many cancer-related deaths worldwide; in China, it is the second most prevalent …

Hepatocellular carcinoma (HCC) is the fifth most common cancer worldwide and the fourth
most common cancer among men in South Korea, where the prevalence of chronic hepatitis …

The guideline for the management of hepatocellular carcinoma (HCC) was first developed in
2003 and revised in 2009 by the Korean Liver Cancer Study Group and the National Cancer …

Approaches to the diagnosis and management of hepatocellular carcinoma (HCC) are
improving survival. In the Surveillance, Epidemiology, and End Results‐13 registries, HCC …

Hepatocellular carcinoma (HCC) is the fourth-leading cause of cancer-related mortality
worldwide and the fastest-rising cause of cancer-related death in the United States. Given …

Hepatocellular carcinoma (HCC) is the fourth most common and the third most lethal cancer
in China. An updated version of consensus-based recommendations on the management of …